Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Merck

LCD TVs are dead in the water and OLED is the future

LCD TV screens have stopped innovating, making it crystal clear OLED is the future.

TechRadar

Michael Hiltzik: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's nonsense

No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees.

Los Angeles Times

Irvine healthcare firm plan £250,000 solar power project

North Ayrshire Council will decide on the application from Merck.

Daily Record

From analysis to the latest developments in health,
read the most diverse news in one place.

Merck sues to block lower Medicare costs

The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments

Salon

Merck Sues HHS, Claims Drug Price Negotiation Program Violates First and Fifth Amendment

Pharma has a "choice": Negotiate with HHS or pay $10 million "tax" per day.

Reason

Merck sues federal government, calling plan to negotiate Medicare drug prices 'extortion'

Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion

The Independent UK

Merck sues government over drug price negotiation - Roll Call

The lawsuit argues that the negotiation program violates the Fifth Amendment by not paying the company “just compensation” for its products.

Roll Call

Read news from The Economist, FT, and more,
with one subscription

New Stirling life sciences facility to bring 30 new jobs to city

Merck say “30-plus” jobs are expected to add to an existing workforce of 99.

Daily Record

Merck makes €35 million investment in Scottish sites

The expansion plan should create nearly 500 new jobs in Glasgow and Stirling

Insider UK

Making the Case for Covered Call Strategies

During times of uncertainty, an investor can use a covered call to deliver downside protection while capturing upside gains. Here’s how it works.

Kiplinger

Vaccines using mRNA can protect farm animals against diseases traditional ones may not – and there are safeguards to ensure they won't end up in your food

While effective vaccines for COVID-19 should have heralded the benefits of mRNA vaccines, fear and misinformation about their supposed dangers circulated at the same time. These misconceptions about mRNA vaccines have recently spilled over into worries about whether their use in agricultural animals could expose people to components of the…

The Conversation

1 Pharma Stock You'll Regret Not Buying Earlier

The long-term prospects of Merck (MRK) look bright due to its latest acquisitions and solid drug pipeline. Therefore, investing in this stock could help generate substantial returns in the long run. Keep reading….

StockNews.com

Stocks Close Mildly Higher on Q1 Earnings Optimism

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.06%. Stock indexes Monday posted moderate gains. An increase in...

Barchart

Stocks Undercut by Higher Bond Yields and Weakness in Chip Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. U.S. stock indexes this morning are mixed. An increase...

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Markets Today: Stock Index Futures Mixed on Pressure from Higher Bond Yields

Morning Markets June S&P 500 futures (ESM2 3) this morning are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.03%. U.S. stock index futures this morning are mixed. An increase in M&A activity is positive for stocks after Merck said it would acquire Prometheus Biosciences for...

Tribune News Service

Study: Vaccine helps drug keep melanoma patients cancer-free

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

The Guardian - UK

Does the future of medicine lie in space?

Earth’s gravity makes it harder to cultivate the proteins needed to study diseases and pathogens. And although the cost of space travel is high, private enterprise is stepping in

Foreign Policy

Insurance Agencies Would Love to Know Who Blew Up Nord Stream

An era of gray zone warfare and sabotage creates tough financial questions.

Get all your
news in one place.

100's of premium titles.
One news app.

Bangkok Post

Pfizer buys biotech firm Seagen for $43 billion

WASHINGTON - US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.

The Conversation

What are these 'cancer vaccines' I'm hearing about? And what similarities do they share with COVID vaccines?

Barely a month goes by without headlines announcing yet another advancement in cancer vaccines.

The New Daily

What are these ‘cancer vaccines’ making news? Are there similarities with COVID vaccines?

Using the same mRNA technology as COVID vaccines, cancer vaccines are an emerging personalised treatment for cancer.

Insider UK

Merck Livingston announces 15 new jobs and £2.6 million investment

Strategic partnership signed with Scottish Enterprise to develop novel quality control kit

Fortune

The cost of cybersecurity insurance is soaring–and state-backed attacks will be harder to cover. It’s time for companies to take threats more seriously

State-backed attacks are on the rise–and the insurance sector is increasingly excluding them from coverage.

Tribune News Service

Merck COVID drug linked to new virus mutations, study says

Merck & Co.’s COVID-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s genetic code.

The Independent UK

Meet the German shepherd who was the richest dog in the world — and had a huge secret

“Gunther’s Millions”, a new Netflix documentary, investigates the story of Gunther, one in a long line of German Shepherds who had supposedly inherited a fortune from their late owner. Clémence Michallon reports

1 … 7 8 9 10

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.